Infinata is a wholly-owned subsidiary of the Financial Times Group, publisher of the Financial Times newspaper and FT.com. FT Group is a division of Pearson plc, the international media group.
Incorporated in 1999, Infinata (developers of BioPharm Insight) has since become the fastest growing business in its sector. In addition to expanding its coverage, the company continues to launch ground-breaking products and services.
History of BioPharm InsightInfinata provides online services that help organizations turn information into insight. We specialize in Web-based solutions for:
- targeted market research
- increased sales productivity
- optimized business analysis
Our turnkey products and customized solutions help business managers at all levels in an organization effectively manage large amounts of data and disseminate knowledge. As a result, their people can quickly capitalize on critical business opportunities.
The primary factors contributing to Infinata’s success, as well as the success of our clients, are our:
- in-house research capabilities and proprietary data
- industry-specific knowledge for each target market
- easily configured Web-based software and database technology
- flexible and scalable applications that clients can adapt to changing business requirements
Other Offerings: BioPharm Clinical | BioPharm Devices
 |
 |
(C) 2010 Infinata. All rights reserved.